# A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I

> **NCT03812263** · PHASE1,PHASE2 · COMPLETED · sponsor: **Rocket Pharmaceuticals Inc.** · enrollment: 9 (actual)

## Conditions studied

- Leukocyte Adhesion Defect - Type I

## Interventions

- **BIOLOGICAL:** RP-L201

## Key facts

- **NCT ID:** NCT03812263
- **Lead sponsor:** Rocket Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-30
- **Primary completion:** 2023-09-12
- **Final completion:** 2023-09-12
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03812263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03812263, "A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03812263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*